Isolating Endothelial Cell-Derived Extracellular Vesicles Using Microfluidics
Author Information
Author(s): Akbar Naveed, Luciani Evelyn Grace, Ahmad Raheel, Lee Dasol, Veiga Sara, Rabe Daniel Christopher, Stott Shannon Leigh
Primary Institution: University of Oxford; Massachusetts General Hospital Cancer Center, Harvard Medical School
Hypothesis
Can the EVHB-Chip effectively isolate VCAM-1+ endothelial cell-derived extracellular vesicles for analysis?
Conclusion
The study demonstrates a novel method for isolating VCAM-1+ extracellular vesicles, which may enhance understanding of their role in cardiovascular and metabolic diseases.
Supporting Evidence
- VCAM-1+ endothelial cell-derived extracellular vesicles are increased in cardiovascular disease.
- The EVHB-Chip showed significant binding to VCAM-1+ cells compared to control devices.
- TNF-α stimulation increased VCAM-1 levels in endothelial cells.
- Captured extracellular vesicles were positive for known EV markers like CD9 and CD63.
Takeaway
Researchers created a special chip to catch tiny bubbles from blood cells that can help us understand heart diseases better.
Methodology
The study used a microfluidic device coated with anti-VCAM-1 antibodies to selectively capture VCAM-1+ endothelial cells and their derived extracellular vesicles.
Potential Biases
Potential variability in antibody concentrations and efficiency in capturing VCAM-1+ EVs.
Limitations
The study primarily focuses on in vitro experiments, and further in vivo investigations are necessary to validate findings in physiologically relevant settings.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website